January 18, 2024 02:15 PM EST
Deals
Pharma

Sun Phar­ma to buy out the rest of Taro's own­er­ship

Katherine Lewin

News Reporter

Gener­ics com­pa­ny Sun Phar­ma will con­vert its ma­jor­i­ty own­er­ship of Is­rael’s Taro Phar­ma­ceu­ti­cal In­dus­tries in­to a full takeover of the com­pa­ny, buy­ing up the shares …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times